Pharma Journalist - Page 77 of 956 -

Sanofi, Regeneron Expand Antibody Collaboration With $8B Deal

Abogen, Novartis Sign $7.2B RNA Therapeutics Deal

CAS, Novartis Partner on AI-Ready Reaction Data for Drug Discovery

US Regulatory Review Update: Tolebrutinib for Non-Relapsing Secondary Progressive MS

Minovia Therapeutics’ MNV-201 Granted FDA Fast Track Designation for Myelodysplastic Syndrome

Novo Nordisk: Ozempic Lowers Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide in Real-World Study

FUJIFILM Biotechnologies Expands Partnership with argenx to Include U.S. Manufacturing

Roche to Acquire 89bio in Merger Deal, Gaining Phase 3 MASH Therapy Candidate

Biogen’s ZURZUVAE Approved in Europe as First Treatment for Postpartum Depression

VectorY and Shape Therapeutics Partner to Develop AAV5-Based Vectorized Antibodies for Neurodegenerative Diseases

Wheeler Bio and MindImmune Therapeutics Partner to Support Alzheimer’s Prevention Program MITI-101

Novo Nordisk’s Oral Semaglutide Yields 16.6% Weight Loss in Obesity Study

GSK to Invest $30 Billion in U.S. R&D and Manufacturing Over Next 5 Years